Complete Filing Data
CRESUD INC reported Selling Expense of $83.10 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean CRESUD INC did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $224.37B | $148.84B | $78.18B | $135.82B | -$86.62B | $49.27B | -$61.18B | $27.42B | $3.62B |
| Gross Profit | $368.05B | $406.48B | $369.17B | $340.10B | $79.39B | $35.00B | $23.98B | $33.39B | $25.20B |
| General And Administrative Expense | $111.00B | $118.30B | $143.90B | $72.46B | $18.27B | $8.44B | $6.09B | $10.88B | $7.98B |
| Cost Of Sales | $570.74B | $571.31B | $597.25B | $558.94B | -$119.60B | $55.63B | $26.73B | $62.08B | $42.63B |
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | $26.89B | $45.94B | $8.18B | -$1.56B | -$15.68B | $18.14B | -$7.33B | -$3.45B | -$798.0M |
| Revenue | $42.41B | $51.07B | $47.53B | ||||||
| Profit Loss From Continuing Operations | $220.95B | -$191.92B | -$105.79B | $346.23B | $35.08B | $107.95B | -$47.87B | -$9.02B | -$5.21B |
| Profit Loss Before Tax | $295.41B | $62.58B | $29.79B | $520.42B | $41.35B | $75.69B | -$47.09B | -$18.99B | -$3.38B |
| Comprehensive Income Attributable To Noncontrolling Interests | $98.57B | -$49.02B | $205.38B | $106.23B | -$8.57B | $23.78B | -$45.88B | $38.34B | $6.67B |
| Profit Loss Attributable To Owners Of Parent | $96.15B | $127.20B | $228.76B | $297.05B | $3.93B | -$26.80B | $6.11B | -$624.0M | |
| Profit Loss Attributable To Noncontrolling Interests | $128.22B | $21.64B | $177.72B | $207.53B | $16.07B | -$13.93B | $21.31B | $4.25B | |
| Other Comprehensive Income | -$46.50B | -$107.31B | $46.85B | -$168.72B | $11.42B | -$804.0M | $16.69B | $4.05B | |
| Comprehensive Income Attributable To Owners Of Parent | $79.30B | $90.55B | $247.94B | $229.63B | $2.42B | -$27.08B | $5.78B | $1.01B | |
| Comprehensive Income | $177.87B | $41.53B | $453.32B | $335.86B | $31.42B | -$41.53B | $44.11B | $7.67B | |
| Revenue From Sale Of Agricultural Produce1 | $4.64B | $10.00B | -$13.15B | -$16.01B | -$2.09B | $1.62B | |||
| Sales Revenue Net | $42.41B | $51.07B | $47.53B |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $250.86B | $159.83B | $201.69B | $75.26B | $45.14B | $151.59B | $89.30B | $85.94B | $73.01B | $33.70B |
| Property Plant And Equipment | $712.68B | $711.71B | $753.95B | $128.12B | $65.78B | $90.05B | $81.27B | $52.07B | $67.35B | |
| Cash Flows From Used In Operating Activities | $151.32B | $115.45B | $188.03B | $174.66B | $31.42B | $88.01B | $25.55B | $24.15B | $16.55B | |
| Cash Flows From Used In Investing Activities | -$80.57B | $129.06B | $77.26B | $103.27B | $258.54B | $111.46B | $10.55B | -$31.55B | -$4.63B | |
| Cash Flows From Used In Financing Activities | $86.18B | -$310.52B | -$471.73B | -$296.48B | -$189.64B | -$191.05B | -$25.74B | -$4.01B | $4.24B | |
| Trade And Other Current Receivables | $442.85B | $364.81B | $403.10B | $71.82B | $37.26B | $65.66B | $38.45B | $26.78B | ||
| Trade And Other Current Payables | $330.52B | $348.62B | $393.50B | $66.66B | $32.12B | $53.81B | $32.30B | $28.03B | ||
| Shareholders Equity According To Corresponding Statement | $970.59B | $968.54B | $1.09T | $177.43B | $53.21B | $37.79B | $24.04B | $37.25B | ||
| Payroll And Social Security Current Liabilities | $38.07B | $28.15B | $35.19B | $332.0M | $221.0M | $371.0M | $197.0M | $118.0M | ||
| Noncurrent Restricted Cash And Cash Equivalents | $0.00 | $3.79B | $6.23B | $1.01B | $331.0M | $2.91B | $4.55B | $3.39B | ||
| Noncurrent Liabilities | $1.87T | $1.74T | $2.03T | $376.96B | $267.05B | $588.67B | $470.77B | $345.26B | ||
| Noncurrent Derivative Financial Assets | $2.47B | $1.71B | $2.03B | $140.0M | $123.0M | $246.0M | $153.0M | $47.0M | ||
| Noncurrent Biological Assets | $43.55B | $39.07B | $48.20B | $13.09B | $5.33B | $2.64B | $1.81B | $1.41B | ||
| Noncurrent Assets | $3.84T | $3.86T | $4.43T | $897.33B | $441.43B | $684.79B | $507.28B | $398.20B | ||
| Liabilities | $2.88T | $2.66T | $3.04T | $695.11B | $382.54B | $848.31B | $598.83B | $434.21B | ||
| Investments In Subsidiaries Joint Ventures And Associates | $187.54B | $191.85B | $205.54B | $38.63B | $21.32B | $112.84B | $44.87B | $40.72B | ||
| Goodwill | $28.50B | $101.06B | $51.63B | $9.23B | $4.90B | $42.34B | $26.02B | $19.59B | ||
| Equity And Liabilities | $5.09T | $4.84T | $5.54T | $1.14T | $556.18B | $1.03T | $726.03B | $557.67B | ||
| Deferred Tax Assets | $12.88B | $13.60B | $7.40B | $140.0M | $808.0M | $1.39B | $772.0M | $1.83B | ||
| Current Tax Liabilities Current | $56.75B | $9.34B | $8.56B | $33.26B | $1.80B | $1.24B | $699.0M | $926.0M | ||
| Current Liabilities | $1.00T | $919.00B | $1.01T | $318.15B | $115.49B | $259.64B | $128.06B | $88.95B | ||
| Current Derivative Financial Assets | $6.78B | $9.38B | $31.92B | $6.04B | $1.04B | $482.0M | $162.0M | $241.0M | ||
| Current Biological Assets | $105.68B | $81.26B | $96.83B | $19.86B | $11.02B | $4.17B | $3.80B | $1.42B | ||
| Current Assets | $1.25T | $984.87B | $1.11T | $243.58B | $114.76B | $347.00B | $218.76B | $159.47B | ||
| Assets | $5.09T | $4.84T | $5.54T | $1.14T | $556.18B | $1.03T | $726.03B | $557.67B | ||
| Rightofuse Assets | $122.04B | $111.52B | $97.07B | $54.43B | $15.05B | $54.01B | $24.59B | |||
| Deferred Tax Liabilities | $863.55B | $889.73B | $1.01T | $250.61B | $134.85B | $74.30B | $6.22B | |||
| Foreign Exchange Loss Gain On Cash And Changes In Fair Value Of Cash Equivalents | $28.46B | $51.16B | $37.10B | $0.00 | -$675.0M | $21.31B | -$10.14B | |||
| Cash Flows From Used In Operating Activities Discontinued Operations | $0.00 | $0.00 | $10.75B | $58.74B | $6.35B | $14.12B | $6.71B | |||
| Cash Flows From Used In Operating Activities Continuing Operations | $35.97B | $47.01B | $20.67B | $29.28B | $19.19B | $10.03B | $9.84B | |||
| Cash Flows From Used In Investing Activities Continuing Operations | $14.92B | $27.80B | $102.63B | $11.25B | $16.63B | -$22.49B | -$11.18B | |||
| Cash Flows From Used In Financing Activities Discontinued Operations | $0.00 | $0.00 | -$63.98B | -$172.65B | $7.46B | $8.47B | -$5.48B | |||
| Cash Flows From Used In Financing Activities Continuing Operations | -$90.74B | -$79.80B | -$125.66B | -$18.40B | -$33.19B | -$12.48B | $9.72B | |||
| Purchase Of Intangible Assets Classified As Investing Activities | $2.75B | $3.00B | $1.91B | $921.0M | -$300.0M | $174.0M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Proceeds From Sales Of Investment Property | $7.76B | $49.93B | $117.29B | $208.06B | $65.52B | $961.0M | $1.46B | $887.0M | $645.0M |
| Increase Decrease In Cash And Cash Equivalents Discontinued Operations | $156.94B | -$66.01B | -$206.44B | -$18.54B | $102.68B | -$13.70B | $7.73B | $13.53B | $7.77B |
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | $27.94B | $108.84B | $92.42B | $23.02B | $3.38B | $31.0M | $51.0M | $18.0M | |
| Proceeds From Loans Granted | $1.17B | $2.32B | $2.82B | $3.63B | $237.0M | $0.00 | $311.0M | ||
| Net Cash Provided By Used In Operating Activities Continuing Operations | $159.71B | $127.25B | $217.98B | $184.49B | $20.81B | $30.02B | $6.90B | ||
| Proceeds From Contributions Of Noncontrolling Interests | $0.00 | -$1.15B | $2.26B | $0.00 | $2.76B | $791.0M | $433.0M | ||
| Net Cash Provided By Used In Investing Activities | $73.66B | $60.55B | $15.85B | ||||||
| Net Cash Provided By Used In Financing Activities | -$54.17B | -$109.08B | -$38.65B |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Selling Expense | $83.10B | $84.19B | $70.22B | $58.79B | $14.66B | $7.95B | $3.29B | $13.49B | $9.92B |
| Finance Income | $9.42B | $91.08B | $11.39B | $10.47B | $2.32B | $754.0M | $312.0M | $1.48B | $1.31B |
| Other Operating Income Expense | -$4.99B | $29.80B | -$46.17B | -$6.13B | -$8.07B | $4.10B | $1.10B | $3.66B | -$298.0M |
| Other Finance Income Cost | $108.01B | $259.46B | $179.24B | $286.82B | $70.69B | -$25.76B | $5.98B | -$22.17B | $9.23B |
| Inflation Adjustment | $11.44B | -$39.53B | $59.59B | $3.20B | $2.02B | -$269.0M | -$1.03B | $321.0M | $2.41B |
| Finance Costs | $81.29B | $102.46B | $122.82B | $124.74B | $53.10B | $25.12B | $22.57B | $26.38B | $14.86B |
| Repurchase Of Bonds Notes And Debentures | -$4.79B | -$5.58B | -$23.67B | $6.41B | $3.68B | $1.33B | $1.19B | ||
| Investment Property | $2.40T | $2.44T | $3.04T | $1.0K | $313.37B | $345.71B | $335.02B | $254.46B | |
| Inventories | $177.41B | $162.12B | $146.16B | $28.93B | $17.52B | $13.62B | $17.76B | $3.67B | |
| Acquisition Of Non Controlling Interest In Subsidiaries | $0.00 | $0.00 | -$265.0M | -$1.48B | $1.48B | $1.63B | $667.0M | ||
| Shortterm Borrowings | $535.76B | $483.71B | $531.98B | $205.38B | $74.51B | $147.78B | $80.38B | $49.91B | |
| Noncurrent Provisions | $32.43B | $30.09B | $33.49B | $1.10B | $638.0M | $4.64B | $11.48B | $5.55B | |
| Noncontrolling Interests | $1.24T | $1.21T | $1.42T | $268.37B | $120.44B | $145.68B | $103.16B | $86.21B | |
| Longterm Borrowings | $807.35B | $663.07B | $825.42B | $99.52B | $120.09B | $481.27B | $397.41B | $291.64B | |
| Current Provisions | $5.24B | $6.40B | $4.49B | $451.0M | $248.0M | $3.67B | $2.48B | $1.65B | |
| Obtaining Payment Of Short Term Loans Net | -$11.20B | $45.38B | $21.67B | $18.57B | -$28.85B | $7.32B | $3.38B | ||
| Interest Paid Classified As Financing Activities | $89.34B | $176.01B | $177.50B | $129.84B | $21.91B | $20.06B | $14.27B | $12.10B | |
| Financial Results Net | $47.58B | $208.55B | $127.40B | $175.75B | $21.94B | -$50.40B | -$12.20B | ||
| Changes In Non Controlling Interest | -$12.51B | $20.24B | -$3.37B | $15.83B | $4.01B | -$7.40B | -$2.22B | ||
| Capital Contributions In Associates And Joint Ventures | $0.00 | $89.0M | $5.00B | -$149.0M | -$4.69B | $47.0M | |||
| Acquisition And Improvement Of Investment Properties | $39.30B | $17.93B | $30.58B | $49.13B | -$3.53B | $9.06B | $6.43B | ||
| Dividend Distribution | -$134.46B | -$375.04B | -$225.12B | -$69.48B | -$12.97B | -$106.65B | |||
| Repayments Of Noncurrent Borrowings | $338.74B | $401.20B | $570.90B | $337.53B | $330.81B | $75.91B | |||
| Purchase Of Financial Instruments Classified As Investing Activities | $757.85B | $771.93B | $287.11B | $217.75B | -$59.25B | $34.31B |
Most recent annual filing with the SEC: October 24, 2025
Data sourced from SEC EDGAR public filings as of August 4, 2026.